Nexus AG

Quarterly Report • Aug 19, 2013

HALF YEAR REPORT AUGUST 19, 2013

Letter to Our Stockholders

Dear Stockholders,

the NEXUS team again recorded great results in the fi rst half-year 2013: a strong increase in sales, considerable improvement of earnings and very interesting new orders in addition. With these interim results, we are starting with an extraordinary amount of motivation into the second half-year 2013.

Sales increased by approx. 19.5% in the first half-year 2013, and the result before taxes and interest improved by approx. 18.2% during the same period. As a result, we also continued our dynamic growth course in connection with continual improvement of earnings in the first half-year 2013.

This is undoubtedly a notable achievement following the substantial improvement of growth and earnings of the past few years. We can only continue to achieve such good performance if we consistently continue to promote the success factors of our company: customer-focus and joy in innovation.

We have addressed the issue of customer satisfaction over the past months with on-going staff hirings in the service sector and further investments in developing existing products. Today, we can support our regular customers more intensively and fulfill individual customer requirements even better.

At the same time we have demonstrated the joy in innovation that the market expects from us, in that we have invested in new business areas and markets, These include the new REHAbilitation solution (NEXUS / REHA), the solution for inpatient and outpatient care services (NEXUS / HOME and SYSECA) and our offer for process consulting (ASS.TEC). We have simultaneously expanded our marketing activities in France and Austria and enhanced our range of products in NEXUS / DIS in endoscopy and cardiology. We have supported and consequently accelerated our respective developments in business areas with company acquisitions.

The reduced earnings connected with this expansion are shown in the current results, However, we are already seeing the successes of this agile entrepreneurial strategy now, earlier than expected.

Highlights 1st half-year 2013 Company's performance

• • Substantial sales increases in the 1st half-year
• • Successful production start NEXUS / RIS
• • Entry into the home care market through the acquisition of SYSECA AG
• • Marienhospital Gelsenkirchen decides "Private cloud" - announcement for NEXUS

We received orders from a total of 90 hospitals, rehabilitation institutions and senior citizen homes in the first half-year. This included six hospitals from a call for bids for a complete hospital system, which we were able to win with NEXUS / HIS. The order from the Marien Hospital Gelsenkirchen is to be emphasized in this context, where we will be responsible for the complete IT system, including operation, in the future. This is a large order, which confirms the competency of NEXUS as a software company with a wide range of products in the healthcare sector.

The number of incoming orders greatly increased in France and Austria, 14 hospitals decided in favor of our OP documentation or CSSD software in France. We already succeeded in placing our new products for central sterilization in three central sterilization departments in Austria. We have also already received an initial order from Libya for equipping the hospital in Benghazi and have delivered it in part.

NEXUS is positioned more widely and stably today than in the past. Our wide range of products in the meantime is already providing us with additional marketing potential today. Our incoming orders are smoothing out and coming from different business areas. Consequently, we are able to react very dynamically to different customer groups and the developments in various markets.

This increased complexity is also creating very varied challenges, which we have to face actively. Consequently, the requirements of our large projects will also be in the forefront this year. We are extremely pleased that we were able to implement numerous new applications and development projects or advance them considerably in the first half-year. We were able to meet essential delivery deadlines, and we are confident that we can fulfill additional deadline and performance promises to our customers during the course of the year.

Dear Stockholders, I want to thank you again for your trust!

Sincerely,

Dr, Ingo Behrendt CEO - NEXUS AG

Key Figures	06/30/2012		06/30/2011
	KEUR	%	KEUR
Sales	34,372	19.5	28,768
Sales Healthcare Software	30,340	13.2	26,812
Sales Healthcare Service	4,032	106.1	1,956
Sales National	20,615	36.4	15,109
Sales International	13,757	0.7	13,659
Result before tax and interest (EBIT)	3,250	18.2	2,749
Result of the period before tax	3,298	10.7	2,978
Result of the period	3,321	15.6	2,873
EBITDA	6,330	9.6	5,774
Result per Share	0,23	9.5	0,21
Investments in intangible and tangible assets	2,060	-13.4	2,379
Depreciation	3,230	6.8	3,025
Net Liquidity	22,656	-4.2	23,645
Cash Flow from operative activities	3,583	-35.4	5,545
Employees (as of the reporting date)	591	23.6	478

Interim Annual Report- Sales: Substantial Increase in First Half Year

NEXUS Group sales increased from KEUR 28,768 to KEUR 34,372 (+19,5%) in the fi rst six months of the year 2013.

As a result, the uninterrupted positive development of sales of the NEXUS Group of many years could be continued in the fi rst half-year 2013. In a quarterly comparison to the previous year, sales of the Group increased from KEUR 16,604 (Q1-2013) to KEUR 17,767 in Q2-2013 (+7.0%). The sales of the companies acquired last year are included in that. New companies were not consolidated in the second quarter. The international share of total business volume was 40.0% following 47.5% (1st half-year 2012). Sales developed very positively in France and for the fi rst time in Arab regions again. Sales effects for exchange rate fl uctuations were not signifi cant compared to 31 December 2012.

Growth in the fi rst half-year was generated equally in both business segments of NEXUS AG. Sales in the area of Healthcare Service increased by approx, 13.2% from KEUR 26,812 (1st half-year 2012) to KEUR 30,340. KEUR 4,032 were recorded in the Healthcare Service segment in the 1st half-year 2013 following KEUR 1,956 in the previous year. This contains the sales of approx. KEUR 2,196 of ASS.TEC GmbH, which was initially consolidated in the fi rst half-year. The segment would have increased by 9% without these sales.

The positive development of sales was also refl ected in the result. The result before taxes reached KEUR 3,250 in the 1st half-year 2013 (+18.2%) following KEUR 2,749 in the previous year,

Group Sales in KEUR (1st half-year) +19.5% as of previous year

Highlights 1st half-year 2013 Sales Result

• • 19.5% sales increase in fi rst half-year 2013 from € 28.8 million (1st half-year 2012) to € 34.4 million
• • 18.2% increase in result before taxes and interest from € 2.8 million to € 3.3 million
• • Liquid assets by € 22.6 million (06/30/2013)

Result before tax and interest (EBIT) (1st half-year) in KEUR +18.2% as of previous year

Staff

NEXUS Group employed a total of 591 people as of 30 June 2013 (1st half-year 2012: 478 employees). The great majority of the employees (526) work in the Healthcare Software segment (1st half-year 2012: 443). The Health Care Service segment employed 65 people (1st half-year 2012: 35). The increase is due to an increase of acquisitions and adjustments in existing business areas.

The EBITDA increased to KEUR 6,330 (+9.6%) following KEUR 5,774 (1st half-year 2012).

The operating result after taxes improved from KEUR 2,873 by approx. 15.6% to KEUR 3,321. The effective tax burdens remain as previously due to losses of the individual companies carried forward. Write-offs increased slightly compared to the previous year at € 3,23 million (1st half-year 2012: € 3.02 million). Capitalized goods/services on own account decreased at the same time at € 1.84 million compared to the previous year (-10,6%). The return on sales after taxes is 9.7%. Earnings per share amounted to € 0,23.

One-time effects and expenses for setting up new business areas and the integration of acquired companies are shown in their full amount in the operating result.

The segment results developed differently. While the Healthcare Service segment was substantially higher than the level of the previous year with a result before taxes of KEUR 3,030 (+19.4%) compared to KEUR 2,538 in the previous year (1st half-year 2012),

the result of the Healthcare Service segment was approx. 10% higher than that of the previous year (1st half-year 2012) at KEUR 485. The area is burdened by the cost of the development of the range process consulting through integration expenses for ASS.TEC GmbH.

The operative cash fl ow is KEUR 3,583 and has increased compared to the previous year (1st half-year 2012: KEUR 5,545). The reason lies in particular in the reduction of liabilities from deliveries and services (€ 1.8 million). Dividend payments amounting to KEUR 1,657 were due in the fi rst half-year. Liquid assets amount to KEUR 22,656 and consequently are at a high level.

The equity ratio of NEXUS AG is 69%.

The balance sheet total decreased from KEUR 101,167 to KEUR 99,826 compared to 31 December 2012. There are no essential bank liabilities, intangible assets, goodwill and balanced-out deferred taxes add up to a total of approx. € 48.8 million following approx. € 37.4 million in the 1st half-year 2012. This increase is especially due to the initial consolidation of the goodwill and technology of E&L GmbH, Erlangen.

There have been no essential changes of the net worth position of the Group compared to 31 December 2012.

Sales by divisions

	01/01/ - 06/30/13	01/01/ - 06/30/12	∆ IN %	04/01/ - 06/30/13	04/01/ - 06/30/12	∆ IN %
	KEUR	KEUR		KEUR	KEUR
Healthcare Software	30,340	26,812	13.2	15,831	13,959	13.4
Healthcare Service	4,032	1,956	106.1	1,937	954	103.0
Total	34,372	28,768	19.5	17,768	14,913	19.1

Sales by regions

	01/01/ - 06/30/13	01/01/ - 06/30/12	∆ IN %	04/01/ - 06/30/13	04/01/ - 06/30/12	∆ IN %
	KEUR	KEUR		KEUR	KEUR
Germany	20,615	15,109	36.4	11,136	8,556	30.2
Switzerland	11,204	11,401	-1.7	5,494	5,307	3.5
Austria	619	593	4.4	236	298	-20.8
Italy	7	5	40.0	5	3	66.7
Rest of world	1,927	1,660	16.1	897	749	19.8
Total	34,372	28,768	19.5	17,768	14,913	19.1

NEXUS enhances the business area "NEXUS / HOME" with an outpatient care solution

Care and medical treatment of people in their home environments are becoming an increasingly important aspect in the healthcare system. This includes increasingly intensive collaboration between inpatient and ambulatory medical care.

We have included this trend in our strategy with acquisition of SYSECA Informatik AG, Lucerne, and integrated the industry specialists of ambulatory medical care (SPITEX) into NEXUS. SYSECA is considered the leading market supplier in this segment in Switzerland and provides an ideal enhancement with its software solution to our previous activities in senior citizen homes. This applies not only to the interlinking of the offers to both customer groups, but also to joint development of basic technology and modules within NEXUS.

Collaboration in the area of mobile applications is especially significant. SYSECA has innovative solutions and experience in this area, which will be used in other NEXUS products.

Substantial increase of potential developing mobile solutions

For this reason, capacities in developing mobile solutions in the NEXUS Group will also be shared increasingly. The solution from SYSECA provides an interesting starting point for this, because mobile data entry and communication solutions are already a basic prerequisite today, especially in ambulatory medical care.

With the development of the mobile software solution asebis® smart. SYSECA has succeeded in making a product that does justice to the requirements of mobility in the complete healthcare system in every sense of the word. The solution makes it possible to enter care data (e.g. medication, vital parameters, etc,) and services automatically to a great extent and quickly during a patient visit on site. At the same time, work and nurse scheduling can be retrieved and workflows optimized. All data are available on the mobile terminal even without a network connection, so that consistent documentation of care services is ensured everywhere. Very important: asebis® smart runs on all mobile terminals with the operating systems Android 4, iOS 5, Windows phone or Windows 7/8, so that customers obtain investment security when they select a device.

Chances and Risks

Please refer to the explanations in the annual report of 31 December 2012 for information about the essential chances and risks in the development of NEXUS Group. There have been no essential changes in the meantime.

Outlook: Continued Optimism

We were again able to finish the first half-year 2013 very successfully and consequently continue our unabated positive development of the last year. Sales increases of 19.5% and an increase of the EBIT of 18.2% as well as a strong operative cash flow are pleasing results. In spite of the outstanding rates of increase of the previous years, we are succeeding in improving our figures even more with good products and strongly motivated employees.

This remains a challenge when you consider the high costs of building up new business areas and integrating acquired technologies and companies. However, we are determined to increase our potential with these investments without interrupting our continual upward development of sales and result. This is an ambitious goal, the achievement of which we will have to demonstrate over the next period.

We will also have to demonstrate that we can fulfill the existing project challenges as previously in the sense expected by customers and make the NEXUS success factors of customer-focus and joy in innovation noticeable for customers in the future.

As a result, we are starting the second half-year with an equal degree of confidence and caution. The long-term strategy of our business, our strong product portfolio and the high number of orders on hand will help us to master the challenges of the upcoming months.

Directors Holdings

The director's holders of the Supervisory Board and the Executive Board are as follows on 31 March 2013 in comparison to the previous year: cf. Table.

To 06/30/2013	Number of stock owned	Number of options
Supervisory board
Dr, jur, Hans-Joachim König	101,239 Prev, year (101,239)	0 Prev, year (0)
Prof, Dr, Alexander Pocsay	121,500 Prev, year (121,500)	0 Prev, year (0)
Erwin Hauser	15,000 Prev, year (15,000)	0 Prev, year (0)
Matthias Gaebler	0 Prev, year (0)	0 Prev, year (0)
Diplom-Betriebswirt (FH) Wolfgang Dörflinger	0 Prev, year (0)	0 Prev, year (0)
Prof, Dr, Ulrich Krystek	0 Prev, year (0)	0 Prev, year (0)
Executive board
Dr, Ingo Behrendt (MBA)	169,000 Prev, year (169,000)	0 Prev, year (0)
Ralf Heilig (MBA)	135,350 Prev, year (135,350)	0 Prev, year (0)
Edgar Kuner (Dipl, Engineer)	248,051 Prev, year (248,051)	0 Prev, year (0)

NEXUS on the Finance and Healthcare Markets

Finance- and Event schedule 2013 (status quo: August `13)

Quarterly Report - third quarter	November 11
German equity forum, Frankfurt (D)	November 11 - 13
KTQ-Forum, Berlin (D)	October 18 - 19
IFAS, Romandie, Lausanne (CH)	October 30 - Nov. 01

Following a stock price leap to above € 9,60 for a time at the end of 2012. NEXUS shares started the year 2013 at an initially listed price of € 9,49. The stocks reached a year-low at € 8,68 in January. The highest price of this year was reached with a closing price in XETRA of € 9,90 on 19 July 2013. The price is currently hovering somewhat weaker between € 9,30 and € 9,50.

Decisions NEXUS 2013

• + Zentrum für Kinder und Jugendliche, Altötting
• + Landespfl egeheim Amstetten, Amstetten
• + Centre Clinical Soyaux, Angoulême (F)
• + SeneCura Pfl egezentrum Arnoldstein, Arnoldstein
• + BAG Radiologie & Nuklearmedizin, Aschaffenburg
• + HELIOS Klinikum Bad Saarow, Bad Saarow
• + Altersheim Gellert (Bethesda), Basel (CH)
• + Sozialzentrum Herrenried
• + Dominikus-Krankenhaus Berlin-Hermsdorf, Berlin
• + HELIOS Klinikum Emil von Behring, Berlin
• • Sozialzentrum Bludenz
• + Gosmergartä, Bürglen (CH)
• + Centre Hospitalier Manchester, Charleville (F)
• + Alterszentrum Guggerbach, Davos (CH)
• + Praxisklinik für Radiologie/Nuklearmedizin, Dinkelsbühl
• + Gemeinschaftspraxis f. Pathologie Dresden, Dresden
• + Ferien- und Erholungsheim, Eich (CH)
• + Markus Krankenhaus, Frankfurt
• + Pathologie und Zytologisches Laboratorium Herr Dr. med. Möckel, Freiburg
• + Marienhospital Gelsenkirchen, Gelsenkirchen
• + Alters- und Pfl egeheim Gelterkinden (CH)
• + Ev. Krankenhaus, Gießen
• + Pfl ege- und Sozialzentrum Grafenwörth
• + Landespfl egeheim Gutenstein, Gutenstein
• + Gemeinschaftspraxis für Radiologie und Nuklearmedizin, Herford
• + Sozialzentrum Hohenems
• + Spitex Aemme Plus, Kirchberg (CH)
• + Sozialzentrum Krems
• + Pfl egeresidenz Bethesda, Küsnacht (CH)
• + MDK Baden-Württemberg, Lahr
• + Zentrum Neugut, Landquart (CH)
• + Sozialzentrum Lauterach
• + Universitätsmedizin Mannheim, Mannheim
• + Mariannes Pfl egedienst, München

• + Landespfl egeheim Wiener Neustadt, Neustadt

• + Sozialzentrum Nikitsch, Nikitsch

• + Oberhavel Kliniken GmbH, Oranienburg
• + Haus am Denkmal, Otterbach
• + Sozialzentrum Pöchlarn
• + Polyclinique Poitiers (F)
• + Landespfelgeheim Pottendorf, Pottendorf
• + Sozialzentrum Pressbaum
• + Sozialzentrum Purkersdorf
• + Die Intensivpfl eger, Rauhenebrach
• + Landespfl egeheim Retz, Retz
• + Sozialzentrum Rust, Rust
• + Landespfl egeheim Schreiblingkirchen
• + Helios-Kliniken Schwerin, Schwerin
• + Stiftung Phönix Schwyz Buttikon (CH)
• + Caritas für die Diözese Speyer e.V., Speyer
• + Polyclinique St. Augustin (F)
• + Centre Hospitalier Flemming, St Martin (F)
• • Landesklinikum St. Pölten, St. Pölten (A)
• + Gemeinschaftspraxis Pathologie Starnberg
• + Sozialzentrum Stegersbach
• + St. Annaheim, Steinerberg (CH)
• + Bindersgarten Tägerwilen (CH)
• + Serata, Thalwil (CH)
• + Johanniter-Krankenhaus, Treuenbrietzen
• + Almacasa, Urdorf (CH)
• + Spitex Grauholz, Urtenen-Schönbühl (CH)
• + Bergheim, Uetikon am See (CH)
• + da casa val lumnezia, Vella (CH)
• + SeneCura Pfl egezentrum Villach, Villach
• + Frohmatt, Wädenswil (CH)
• + Pfl ege im Quartier, Waltrop
• + Klinik Amsee GmbH, Waren
• + Im Morgen, Weiningen (CH)
• + Bezirkspfl egeheim Weiz, Weiz
• + Rechenzentrum für Heilberufe, Wesel
• + Landespfl egeheim Wilhelmsburg, Wilhelmsburg
• + RNS Gemeinschaftspraxis Wiesbaden, Wiesbaden

Facts and Figures Group P+L Account as of 06/30/2013 and 06/30/2012 (IFRS)

	04/01/ - 06/30/13	04/01/ - 06/30/12	06/30/2013	06/30/2012
	KEUR	KEUR	KEUR	KEUR
Group statement of income and accumulated earnings
Revenue	17,768	14,913	34,372	28,768
Increase/decrease in finished goods and work in progress	107	4	113	4
Development work capitalized	574	1,147	1,839	2,056
Other operating income	118	869	556	1,293
Cost of materials including purchased services	3,011	3,498	6,600	5,369
Personnel costs	9,803	8,156	19,228	16,456
Depreciation	1,618	1,548	3,230	3,025
Other operating expenses	2,512	2,272	4,572	4,522
Operating Result	1,623	1,459	3,250	2,749
Result from investments valuated at equity	0	0	1	0
Finance Income	43	113	119	280
Finance Expenses	29	1	72	51
Result before tax on profit	1,637	1,571	3,298	2,978
Taxes on profit	18	111	-23	105
Consolidated result	1,619	1,460	3,321	2,873
Consolidated result attributable to:
- Stockholders of NEXUS AG	1,672	1,521	3,515	2,973
- Shares of non-controlling partners	-53	-61	-194	-100
Consolidated surplus per share
Weight average of issued shares in circulations (in thsd)	15,064	14,250	15,064	14,250
- Simple	0,11	0,11	0,23	0,21
- Diluted	0,11	0,11	0,23	0,21

Group statement of income and accumulated earnings from 06/30/2013

until 06/30/2012

	04/01/ - 06/30/13	04/01/ - 06/30/12	06/30/2013	06/30/2012
	KEUR	KEUR	TEUR	TEUR
Consolidated result	1,619	1,460	3,321	2,873
Actuarial profits and losses (after taxes on profit)	10	6	-24	-21
Differences from the conversion of foreign currency (after taxes on profit)	28	346	-384	-145
Market value changes from assets available for sale (after taxes on profit)	0	0	1	0
Other over result	38	352	-407	-166
Over all result of the period	1,657	1,812	2,914	2,707
Of the period result, attributed to:
- Stockholders of NEXUS AG	1,960	1,812	2,858	2,807
- Non-controlling interests	-53	-61	-194	-100

Facts and Figures Balance sheet as of 03/31/2013 and 12/31/2012 (IFRS)

Assets	06/30/2013	06/30/2012
	KEUR	KEUR
Long-term capital
Goodwill	25,014	25,227
Other intangible assets	23,388	24,267
Fixed Assets	1,847	1,925
Shares in affiliated companies	83	43
Credited deferred taxes	4,125	4,174
Other financial assets	91	131
Total long-term capital	54,548	55,767
Short-term capital
Inventories	375	414
Trade receivables and other receivables	18,981	19,144
Receivables from tax on profits	896	509
Other non-financial assets	1,042	1,153
Other financial assets	1,328	1,129
Short-term investments	10,094	10,145
Cash and balance in bank	12,562	12,906
Total Short-term capital	45,278	45,400
Total Assets	99,826	101,167

Facts and Figures Balance sheet as of 06/30/2013 and 12/31/2012 (IFRS)

Equity and liabilities	03/31/2013	03/31/2012
	KEUR	KEUR
Capital and accruals
Subscribed capital	15,105	15,105
Capital reserves	25,757	25,757
Retained earnings	26,874	22,398
Consolidated net income	3,515	6,128
Other cumulated Group result	-1,268	-861
Own shares	-297	-296
Equity capital attributable to stockholders of the parent company	69,686	68,231
Minority interests	-264	-118
Total equity	69,422	68,113
Long-term debts
Pension obligations	2,753	2,597
Debited deferred taxes	3,727	3,840
Other financial assets	4,747	5,030
Total of long-term debts	11,227	11,467
Short-term debts
Accruals	640	1,315
Financial liabilities	175	385
Trade accounts payable	2,305	4,079
Liabilities from tax on profit	364	513
Deferred revenue liability	5,725	3,569
Other non-financial debts	6,254	8,132
Other financial debts	3,714	3,594
Total of short-term debts	19,427	21,587
Total assets	99,826	101,167

	2013	2012
	KEUR	KEUR
1. Cash Flow from Current Business Transactions
Group annual result before tax on income	3,298	2,978
Depreciation and amortization of intangible assets and plant, equipment and other fixed assets	3,230	3,025
Other expenses/income with no impact on cash	51	-2
Increase/decrease in inventories	39	-264
Increase/decrease in trade receivables and other assets that cannot be allocated to investing or fi nancing activities	-423	153
Increases and decreases of accruals insofar as not entered in equity capital	-707	-381
Increase/decrease in trade receivables and other liabilities that cannot be allocated to investing or fi nancing activities	-2,002	-172
Paid interest	-18	-38
Received interest	133	319
Income taxes paid	-32	-80
Income taxes received	14	7
	3,583	5,545
2. Cash Flow from Investment Activities
Cash paid for investments in property, plant and equipment / intangible assets	-2,060	-2,379
Cash received disposal of securities	0	0
	-2,060	-2,379
3. Cash Flow from Financing Activities
Dividend payout	-1,657	-1,428
Purcharse of own share	0	-232
Payments for repayments of loans	-384	-20
	-2,041	-1,680
4. Amount of cash and cash equivalents at end of period
Cash relevant changes in cash and cash equivalents (sum of 1 + 2 + 3)	-518	1,486
Change in currency conversion adjustment	0	0
Cash and cash equivalents at beginning of fiscal year	12,905	12,033
	12,387	13,519
5. Composition of cash and cash equivalents
Cash on hand	12,562	13,587
Bank liabilities due on demand	-175	-68
	12,387	13,519

Facts and Figures Development of Group Equity as of 06/30/2013 and 06/30/2012 (IFRS)

Group Equity Change Statement	Subscribed capital	Capital reserves	Other provisions	Equity diference from curency conversion	Reserve for financial In struments	Reserve for pensions	Consolidated loss carry forward	deficit / profit Consolidated	Own Shares	Equity cap, attributable to stock of parent	Minority interest	Total equity	Authorized capital 13
	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR	KEUR
Consolidated equity as of 12/31/2011	14,305	19,553	0	1,192	0	-1,058	19,155	4,770	-46	57,871	284	58,155	6,488
Transfer of 2011 consolida ted loss to consolidated loss carry-forward							4,770	-4,770
Total of the result entered directly into equity capital				-483		-28				-511		-511
Consolidated net income 06/30/2012								2,973		2,973	-100	2,873
Overall Result of period 2012	0	0	0	-483	0	-28	0	2,973	0	2,462	-100	2,362	0
Increase the authorized capital (AGM 2011)													665
Allocation to retained ear nings as per AGM resolution			3,900				-3,900
Dividend payments							-1,428			-1,428		-1,428
Purchase of own shares		-162					25		-24	-161		-161
Consolidated equity as of 03/31/2012	14,305	19,391	3,900	709	0	-1,086	18,622	2,973	-70	58,744	184	58,928	7,153
Consolidated equity as of 12/31/2012	15,105	25,757	0	1,076	-310	-1,627	22,398	6,128	-296	68,231	-118	68,113	6,353
Profit before tax 2012 entered directly in accumu lated deficit							6,128	-6,128		0		0
Total of the result entered directly into equity capital				-634		-24				-658		-658
Overall Result of the Period	0	0	0	-634	0	-24	0	0	0	-658	0	-658	0
Consolidated net income 2013								3,515		3,515	-146	3,321
Total income for the period 2013	0	0	0	-634	0	-24	0	3,515	0	2,857	-146	2,711	0
Dividend payments							-1,657			-1,657		-1,657
Consolidated equity as of 06/30/2013	15,105	25,757	0	442	-310	-1,650	26,874	3,515	-297	69,436	-264	69,172	6,353

Notes to the consolidated interim fi nancial statements

1. Accounting and Valuation Method

This interim report from the NEXUS Group of 30 June 2013 has been prepared in keeping with the International Financial Reporting Standards (IFRS) as they are applied in the EU. The interpretation of the International Financial Reporting Interpretation Committee (IFRIC) has been taken into account.

The regulations of IAS 34 have been observed in the interim report of 30 June 2013. This refers to a summarized report, which does not contain all information of an IFRS Group Financial Statement, and consequently this report should be read in connection with the Appendix of the Group Financial Statement 2012. The same accounting and valuation methods were used in the Group Financial Statement for the business year 2012.

The report has not been audited.

The Group Financial Statement 2012 and the interim report of 30 June 2013 can be seen on the homepage in the Internet at: http://www.nexus-ag.de

2. Consolidated Group

In addition to the NEXUS AG as parent company, all operatively active domestic and foreign subsidiaries are included in the Group Financial Statement, for which NEXUS AG has the majority of voting rights directly or indirectly.

Four affiliated companies were included in the balance sheets according to the equity method.

List of Subsidiaries Consolidated		06/30/2013	06/30/2012
	Country		Shares of Capital in %
Full Consolidated
NEXUS Digitale Dokumentationssysteme Projektentwicklungsges.m.b.H., Wien	Austria	100.00	100.00
nexus/ccc GmbH, Villingen-Schwenningen	Germany	100.00	100.00
NEXUS . IT GmbH SÜDOST, Singen Hohentwiel	Germany	50.20	50.20
NEXUS . IT GmbH NORD, Villingen-Schwenningen	Germany	100.00	100.00
NEXUS Medizinsoftware und Systeme AG, Altishofen	Switzerland	99.98	99.98
NEXUS Italia S.r.l., Bologna	Italy	100.00	80.00
nexus/inovit GmbH, Ismaning	Germany	100.00	91.49
nexus/cis GmbH, Singen Hohentwiel	Germany	100.00	100.00
nexus/dis GmbH, Frankfurt am Main	Germany	100.00	100.00
NEXUS Schweiz GmbH, Schwerzenbach	Switzerland	100.00	10.00
nexus/qm GmbH, Ismaning	Germany	100.00	100.00
Flexreport AG, Baar	Switzerland	100.00	100.00
nexus/cso GmbH, Villingen-Schwenningen	Germany	100.00	100.00
VEGA Software GmbH, Aachen	Germany	60.00	30.00
Domis Consulting AG, Altishofen	Switzerland	100.00	0.00
Synergetics AG, Altishofen	Switzerland	60.00	0.00
NEXUS / OPTIM S.A.S. Grenoble	France	100.00	0.00
E&L medical systems GmbH, Erlangen	Germany	100.00	0,00
CoM.Med GmbH, Barleben	Germany	100.00	100.00
ASS.TEC Beratungsgesellschaft für Anwendungen, Systeme, Strategien und Technologien mbH, Villingen-Schwenningen	Germany	100.00	100.00
Equity-Consolidated
G.I.T.S. Gesundheitswesen IT-Service GmbH Fürstenfeldbruck, Fürstenfeldbruck	Germany	49.00	49.00
Medidata GmbH, Berlin	Germany	25.00	25.00
Palladium-med GmbH, Berlin	Germany	20.00	20.00

3. Trade accounts receivable and other Assets

In KEUR		06/30/2012		12/31/2012	06/30/2013
	short termed (< 1 year)	long termed (> 1 year)	short termed (< 1 year)	long termed (> 1 year)	short termed (< 1 year)	long termed (> 1 year)
Trade accounts receivable	12,592	-	18,465	-	18,200	-
Receivables from affiliated companies	19	-	22	-	14	-
Gross amount due to customers for projects as an asset	177	-	657	-	767	-
Other Assets	3,291	40	2,282	131	2,370	91
from interests of not payable stocks	7	-	4	-	13	-
from accounts receivable in the range of value added tax	190	-	110	-	140	-
from loans to employee and third	697	40	728	34	638	28
from other	2,397	-	1,440	40	1,579	63
Tags refund claims	122	-	509	-	896	-

The other assets are not interest-bearing and normally are due between 30 and 360 days. Loans to third parties have interest rates of 3,5% and 5% and are normally safeguarded. Receivables from deliveries and services are not interestbearing and normally are due between 30 and 90 days.

There were receivables from deliveries and services in the amount of KEUR 1,462 30 June 2013 (30 June 2012: KEUR 1,485) impaired in value. The development of the value adjustment account is as follows:

Adjustment Account	06/30/12	12/31/12	06/30/13
	KEUR	KEUR	KEUR
Status January, 1st	1,398	1,398	1,581
Allowed expenses allocation	169	643	37
Consumption	-45	-329	-95
Dissolution	-37	-131	-61
Status - end of period	1,485	1,581	1,462

4. Securities

Securities in KEUR	06/30/2012		12/31/2012		06/30/2013
	purchase costs	markes value	purchase costs	market value	purchase costs	market value
Money market bond	2,014	1,686	2,014	1,760	2,014	1,707
Shares in funds	719	372	719	385	719	387
Total	2,733	2,058	2,733	2,145	2,733	2,094

5. Current Liabilities

In KEUR	06/30/2012		12/31/2012		06/30/2013
	short termed (< 1 year)	long termed (> 1 year)	short termed (< 1 year)	long termed (> 1 year)	short termed (< 1 year)	long termed (> 1 year)
Bank loans	68	-	385	-	175	-
Received order deposits	4,303	-	5,973	-	5,725	-
Liabilities from deliveries and services	3,135	-	4,079	-	2,305	-
Liabilities with associated companies	-	-	-	-	-	-
Tax liabilities	948	-	513	-	364	-
Other liabilities	2,532	1,815	5,753	5,030	3,690	4,747
for obligations for salary payments	1,889	-	2,739	-	2,013	-
afor liabilities of social securities	130	-	2,159	-	1,201	-
Others	513	1,815	855	5,030	476	4,747

Conditions of the financial liabilities listed above:

• Liabilities to banks serve solely for short-time payments, Interest due here is paid monthly.
• Average down payments on orders are offset after 12 months.
• Liabilities from deliveries and services are not interest-bearing and normally are due with 30 days.

6. Segment reporting

Business Segments Reporting as of JUNE 30	Healthcare Software		Healthcare Service		Consolidation		Group
	2013 KEUR	2012 KEUR	2013 KEUR	2012 KEUR	2013 KEUR	2012 KEUR	2013 KEUR	2012 KEUR
Sales with third parties	30,340	26,812	4,032	1,956			34,372	28,768
-Deliveries	1,908	1,638	560	751			2,468	2,389
-Services	9,783	9,098	2,705	892			12,488	9,990
-Software updating and hardware maintenance	13,145	11,412	343	155			13,487	11,567
-Licenses	5,504	4,664	424	158			5,929	4,822
Sales between segments	3,977	4,044	2,231	2,314	-6,208	-6,358
Segment sales	34,317	30,856	6,263	4,270	-6,208	-6,358	34,372	28,768
Operating segment result	2,888	2,538	410	440			3,298	2,978
Segment assets	76,313	62,018	1,566	1,178			77,879	63,196

Segmenting according Business Divisions

The Group is split into business units according to products and services for the purpose of company management and has the following business segments required to file reports:

Healthcare Software

In the areas NEXUS / CIS, NEXUS / CSO, NEXUS / DIS as well as NEXUS / HOSPIS, NEXUS / HOME and Domis (both Switzerland) as well as NEXUS / OPTIM (France), software solutions for the healthcare system are developed and marketed in administrative and medical areas. NEXUS provides a hospital information system (HIS) with its core product NEXUS / HIS for the medical sector. The counterpart product NEXUS / PSYCHIATRY is offered for psychosomatic institutions. We provide all administration applications for the Swiss market with the product line NEXUS / HOSPIS.

Highly specialized solutions are available for sterilisation, radiology, gynecology including obstetrics, pathology and cytology. The leading system for QM assessment of all customary processes (NEXUS / HOLL) has also been assigned to this area. NEXUS also expanded its portfolio for quality management software with the product NEXUS / CURATOR. With the product group E&L, the departments endoscopy, cardiology and oncology be served.

Healthcare Service

The Healthcare Service Division covers the services, which are provided by NEXUS / IT companies and ASS.TEC. These including consulting for hospital IT departments, configuration of network, Intranet and Internet solutions, security concepts and the management of IT services with the context of the service company G.I.T.S. Gesundheitswesen IT-Service GmbH, Fürstenfeldbruck.

The Group is mainly controlled according to business divisions due to the chance and risk structure, Consequently, the division according to business divisions is the primary segmentation level.

Transactions between the segments are mainly debited as procurement or manufacturing costs.

7. Seasonal Infl uences on the Business Activities

Seasonal effects resulted in the NEXUS Group operations with regards to the receipt of maintenance revenues in the first quarter of the financial year (deferment of the influences on the result of corresponding incoming payments throughout the year) and significantly greater demand and project accounting in the fourth quarter of the financial year.

Declaration according to § 37y No, 1 WpHG

To the best of our knowledge, and in accordance with the applicable reporting principles for interim financial reporting, the interim consolidated financial statements give a true and fair view ot the assets, liabilities, financial position and profit or loss of the group, and the interim management report of the group includes a fair review of the development and performance of the business and the position of the group, together with a description ot the principal opportunities and risks associated with the expected development of the group for the remaining months of the financial year.

Villingen-Schwenningen, August 19, 2013

NEXUS AG Executive Board

NEXUS AG, Auf der Steig 6, D-78052 Villingen-Schwenningen Telefon +49 (0)7721 8482 -0, Fax +49 (0)7721 8482-888 www,nexus-ag,de, info@nexus-ag,de